Last update 09 Nov 2024

JYB-1904

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
JYB1904
Target
IgE
Mechanism
IgE inhibitors(Immunoglobulin E inhibitors)
Therapeutic Areas
Immune System DiseasesRespiratory DiseasesSkin and Musculoskeletal Diseases
Active Indication
Chronic UrticariaAllergic asthma
Inactive Indication-
Originator Organization
Jiangsu Jiye Biopharmaceutical Co., Ltd.Startup
Active Organization
Jemincare Therapeutics Corp.Jiangsu Jiye Biopharmaceutical Co., Ltd.StartupJiangxi Jemincare Group Co., Ltd.Jiangxi Jemincare Group Co., Ltd.
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

5
Clinical Trials associated with JYB-1904
NCT06509334 / Not yet recruitingPhase 2
A Multicenter, Randomized, Double-blind, Parallel-group, Active-controlled Phase II Clinical Study to Evaluate the Efficacy, Safety and Tolerability of JYB1904 Injection in Adult Patients With Chronic Spontaneous Urticaria Inadequately Controlled by H1 Antihistamines
NCT06438757 / RecruitingPhase 2
Phase IIa Trial to Evaluate the Pharmacokinetic/Pharmacodynamic Characteristics and Safety of JYB1904 in Patients With Allergic Asthma
CTR20241864 / RecruitingPhase 2
评价JYB1904注射液在过敏性哮喘患者中的药动学/药效学特征、安全性Ⅱa期临床试验
[Translation] Phase IIa clinical trial to evaluate the pharmacokinetic/pharmacodynamic characteristics and safety of JYB1904 injection in patients with allergic asthma
100 Clinical Results associated with JYB-1904
Login to view more data
100 Translational Medicine associated with JYB-1904
Login to view more data
100 Patents (Medical) associated with JYB-1904
Login to view more data
100 Deals associated with JYB-1904
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Chronic UrticariaPhase 2
CN
Jiangxi Jemincare Group Co., Ltd.Jiangxi Jemincare Group Co., Ltd.
15 Jul 2024
Allergic asthmaPhase 2
CN
Jiangsu Jiye Biopharmaceutical Co., Ltd.Startup
05 Jun 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free